Health Sciences and Wellness Strategy Consulting

EY-Parthenon Health and Wellness Strategy Consulting teams help life sciences firms boost growth, resilience & agility through digital & value strategies.

Related topics

Strategy by EY-Parthenon

Strategy and Transactions

The team

Kaivaan Movdawalla, Partner and Healthcare Sector Leader, EY-Parthenon India

Kaivaan Movdawalla

Partner and Healthcare Sector Leader, EY-Parthenon India

Sardul Seth, Partner and CHS Consulting Leader, EY India

Partner and CHS Consulting leader, EY India

Srimayee Chakraborty, EY India Business Consulting Partner

Srimayee Chakraborty

Business Consulting Partner, EY India

What the EY-Parthenon Health Sciences and Wellness Strategy Consulting teams can do for you

As the Health Sciences and Wellness industry is transforming, EY-Parthenon Health Strategy Consulting teams can help you answer some of your most critical questions:

How should I refine my business strategy to meet evolving customer needs and the ever-changing health and wellness landscape?
How can I reinvent my operating model and go-to-market strategy?
How can I hone my organization’s strategy to strengthen its operational resilience?
How can I grow market share through investment in digital innovation? How can I leverage the ecosystem to scale my products and services?
What type of transaction or partnership will propel our organization’s growth and pair with consumer needs?
What is the right strategy, to buy, build or partner, and to solve the innovation deficit?

EY-Parthenon Health and Wellness strategy professionals can advise clients on developing growth strategies by providing broad market, competitor and customer insights. But a strategy alone is not enough: we also help organizations execute strategy through real operational change. We help them transform the vision into reality by leveraging strategic, financial and operational perspectives, based on deep sector experience and firmwide knowledge to help enable end-to-end execution.

EY-Parthenon Transaction Strategy teams help clients realize their full potential through fast-tracked, better-informed decisions across the entire deal lifecycle. We guide clients from M&A or divestment strategy, planning, transaction diligence and specialized health due diligence processes, through the integration or separation phases of a transaction — to build long-term value.

EY-Parthenon Turnaround Strategy teams can work with stakeholders to rapidly provide broad strategic, financial, operational, tax, turnaround and restructuring advice to help address business issues in critical and complex situations. From value creation to restructuring, we can help when health and life sciences organizations face financial or operational challenges.

Today’s patients are consumers who expect more from their health and wellness experiences: seamless and simplified processes, faster engagement, virtual and on-site care that is convenient, responsive and effective. Health care organizations are employing data in myriad ways, trying to unlock value and understand all components that contribute to people’s complex health journeys. Data can inform health care providers and payers to understand these drivers and anticipate health care needs. It can also be leveraged to analyze an organization’s internal operations and markets more deeply, to make better informed, strategic choices that bolster financial sustainability.

The massive amount of data, quickly evolving technologies and the many ecosystems in health care can be overwhelming and complex. By focusing on what matters most to health organizations’ consumers and workforce, EY-Parthenon teams can bring together these three critical aspects to help create a technology-enabled, personalized health and wellness experience, supporting health care organizations to advance their missions to serve and improve the health and wellbeing of their populations.

EY-Parthenon Health and Wellness Strategy Consulting teams can help organizations shore up their operations today, while positioning themselves for future success. We understand and work with the broad health ecosystem every day. We understand what consumers demand and what capabilities are needed to meet and exceed their demands. We are here to help organizations succeed in their quest to provide health care that is predictive, personalized and equitable.
The Life Sciences industry has excited the world by leveraging new platforms to address some of society’s most pressing health problems. But the industry is also facing an innovation deficit that requires an ecosystem mindset to find new avenues for growth in particular, as specialty drug spending far outpaces traditional drug spending. New modalities that have emerged include gene and cell therapies, mRNA drugs or vaccines, and complex biologics.

At the same time, costs of capital are increasing, leading an industry that has focused on topline growth to address costs, and strengthen financial and operational resilience. All of this, as digital disrupts operating models and how care is delivered, while regulatory considerations transform pharmaceutical supply chains.

EY-Parthenon Health and Wellness Strategy Consulting teams cover a broad spectrum of life science services for both corporate and private equity clients, including biopharma (branded and generics), medical technology, life science services (CRO and CDMO), diagnostics, life science tools and reagents. Through corporate and growth strategy services, we provide in-depth, real-world perspectives and identify inorganic growth options that lead to M&A programs. Through commercial due diligence services, we help create heavily researched, data-backed insights for our clients. We also help you develop and implement innovation strategies around digital capabilities and emerging technologies.

Through Health and Wellness Strategy Consulting, EY-Parthenon teams help leaders design and deliver transformative strategies to build long-term value.

Our latest thinking

How innovation is shaping India’s key sectors

Explore how innovation in India leads growth across agriculture, energy, healthcare via agritech, clean energy, telemedicine, AI and sustainable tech.

EY India

How GCCs in India are shaping the future of the Life Sciences industry

Explore how India’s GCCs are transforming future of life sciences from handling core and enabling functions to driving innovation, outcome-oriented growth.

Arindam Sen + 1

How to expand future-ready healthcare in India

Read how India’s healthcare is going digital with AI, telemedicine, data analytics, value-based care and interoperable platforms for better access & outcomes

EY India

How Agentic AI can transform industries by 2028

Agentic AI: Transforming industries by 2028 with autonomous decision-making, improved efficiency, and ethical frameworks. Learn how it’s reshaping businesses.

Abbas Godhrawala

Why India should focus on health and education to achieve Viksit Bharat status

Prioritizing health and education is key to harnessing India's demographic dividend. Enhanced spending on these sectors fosters growth, employment, and productivity. Learn more.

D. K. Srivastava

Can AI drive scalable innovation in life sciences?

AI in life sciences is transforming healthcare with advancements in R&D, personalized medicine, MedTech innovation & strategies for sustainable AI adoption.

Suresh Subramanian

How much productivity can GenAI unlock in India? The AIdea of India 2025

Explore AIdea of India 2025 to find out how Gen AI is transforming industries, boosting productivity & reshaping India’s digital economy with innovation.

Mahesh Makhija + 3

AIdea 2025 report - Industries in transformation: Life Sciences

GenAI is reshaping India’s life sciences sector, with 32%–34% productivity gains by 2030. Explore its role in drug discovery, manufacturing, & challenges.

Suresh Subramanian + 1

AIdea 2025 report - Industries in transformation: Healthcare

Explore how GenAI is revolutionizing healthcare in India, improving patient care, diagnostics, and telemedicine, with a 30%–32% productivity boost by 2030.

Kaivaan Movdawalla + 1

What will it take for India to become a global pharma powerhouse by 2047?

Explore India’s roadmap to a $450B pharma industry by 2047, powered by digital transformation, AI-driven innovation, and strategic industry collaboration.

Suresh Subramanian

India’s MedTech transformation: paving the path to global leadership

India's MedTech industry is undergoing a revolution. Explore the latest trends, government support, and the potential for global dominance. Learn more.

Suresh Subramanian

Confronting India’s cancer crisis: The urgent need for affordable care

India battles rising cancer rates. Learn about challenges, prevention, early detection, and affordable treatment options. Know more.

Srimayee Chakraborty

Transforming healthcare in India with Generative AI

Explore how GenAI can revolutionize Indian healthcare by enhancing accessibility, quality & collaboration while integrating tech with thoughtful oversight.

Kaivaan Movdawalla + 1

Driving Competitive Differentiation: M&A Outlook for 2023 in Tech Services

Explore Indias healthcare evolution and future goals in our in-depth analysis. Uncover the strides and vision for a healthier India. Learn more.

EY India

How sustainable practices ensure a green healthcare ecosystem

EY explores how climate change is transforming healthcare system globally, leading to eco-friendly hospitals & sustainable, patient-centric infrastructure.

Nitesh Mehrotra

EY-Parthenon Health Sciences and Wellness Strategy Consulting teams

Kaivaan Movdawalla

Partner and Healthcare Sector Leader, EY-Parthenon India

A seasoned healthcare and life sciences consulting practitioner. Passionate about re-engineering the healthcare ecosystem through operational transformation.

Sardul Seth

Partner and CHS Consulting leader, EY India

As the Consulting Leader for the AIM region, Consumer Products & Retail business, Sardul is responsible for delivering alpha growth in these regions, which have around 40% of the world’s consumers.

New Delhi, India

Srimayee Chakraborty

Business Consulting Partner, EY India

Srimayee joined EY in 2008 and has over 14 years’ experience in business consulting, eight years of which are in the healthcare services space.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.

EY-Parthenon is a brand under which a number of EY member firms across the globe provide strategy consulting services.